Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$69,423,512
+$7,747,034 QoQ
Shares Held
442,978
+9.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#46
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. NVS ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
248,532 | $89,998,407 | |
| 2 | LLY |
ELI LILLY & Co
|
65,278 | $78,296,398 | |
| 3 | NVS |
Novartis AG
This page
|
442,978 | $69,423,512 | |
| 4 | JNJ |
Johnson & Johnson
|
156,545 | $39,757,733 | |
| 5 | AZN |
Astrazeneca PLC
|
192,721 | $36,543,756 | |
| 6 | MRK |
Merck & Co., Inc.
|
252,444 | $32,439,054 | |
| 7 | ABBV |
AbbVie Inc.
|
123,655 | $31,116,544 | |
| 8 | GSK |
GSK plc
|
551,436 | $28,906,275 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,423,512 | 442,978 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $61,676,478 | 403,774 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $56,007,067 | 406,231 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $45,929,284 | 358,151 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $38,712,067 | 319,908 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $29,981,431 | 268,940 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $25,853,515 | 265,682 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $25,764,019 | 223,996 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $22,751,140 | 213,706 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,154,560 | 218,697 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $21,839,710 | 216,299 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $20,707,424 | 203,293 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $20,057,779 | 198,769 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,277,048 | 187,794 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $17,000,111 | 187,391 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $14,053,640 | 184,892 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $14,511,941 | 171,678 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $13,539,649 | 154,298 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $973,803 | 11,133 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $465,900 | 5,697 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $452,276 | 4,957 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $419,877 | 4,912 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $443,254 | 4,694 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $462,540 | 5,319 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $643,259 | 7,365 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $739,081 | 8,964 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||